Crossmark

EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment

Crossref DOI link: https://doi.org/10.1007/s11095-017-2272-6

Published Online: 2017-11-06

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haghiralsadat, Fateme

Amoabediny, Ghasem

Naderinezhad, Samira

Nazmi, Kamran

De Boer, Jantine Posthuma

Zandieh-Doulabi, Behrouz

Forouzanfar, Tymour

Helder, Marco N.
License Information

Text and Data Mining valid from 2017-11-06
More Information

Article History

Received: 4 April 2017

Accepted: 25 September 2017

First Online: 6 November 2017